The KNOW-CKD study: evidence for a link between proteinuria and alterations of mineral metabolism.

Nephrol Dial Transplant

Laboratory and Service of Nephrology, Department of Internal Medicine, University Hospital of Geneva, Geneva, Switzerland.

Published: March 2020

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfz083DOI Listing

Publication Analysis

Top Keywords

know-ckd study
4
study evidence
4
evidence link
4
link proteinuria
4
proteinuria alterations
4
alterations mineral
4
mineral metabolism
4
know-ckd
1
evidence
1
link
1

Similar Publications

Background The National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) developed new race-free eGFR equations and recommended using these new equations in 2021. However, clinical implication of these new equations is not determined in Korean adults. Thus, this study aimed to evaluate performances of these new race-free eGFR equations in predicting complications in Korean chronic kidney disease (CKD) patients.

View Article and Find Full Text PDF

Introduction: Despite the pivotal role of hepcidin in the development of anemia among the patients with chronic kidney disease (CKD), the association between serum hepcidin levels and CKD progression has been never investigated. We here hypothesized that elevation in serum hepcidin levels might be associated with the risk of incident end-stage kidney disease (ESKD) among the patients with pre-dialysis CKD.

Methods: A total of 2,109 patients with pre-dialysis CKD at stages 1 to pre-dialysis 5 were categorized into the quartiles by serum hepcidin levels.

View Article and Find Full Text PDF

Background: Coronary artery calcification (CAC) is a surrogate of cardiovascular events in patients with chronic kidney disease (CKD). To establish the role of circulating osteoprotegerin (OPG) as a cardiovascular biomarker in patients with CKD, we investigated whether an increase in serum OPG levels is associated with the risk of CAC progression.

Methods: A total of 1,130 patients with CKD stage 1 to predialysis 5 were divided into quartiles according to serum OPG levels (Q1 to Q4).

View Article and Find Full Text PDF

Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease.

Nephrol Dial Transplant

November 2024

Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Korea.

Article Synopsis
  • Smoking cessation is crucial for reducing cardiovascular disease and mortality in patients with chronic kidney disease (CKD), but most guidelines are based on general population studies, not specifically CKD patients.
  • An analysis of over 66,000 CKD participants found that both former and current smokers had significantly higher risks of atherosclerotic cardiovascular disease (ASCVD) and mortality, with risk increasing based on smoking history and decreasing with longer cessation periods.
  • Former smokers with CKD need longer cessation periods (at least 20 years) to diminish risks to levels comparable to never smokers, highlighting the necessity for targeted smoking cessation strategies in this population.
View Article and Find Full Text PDF

Background: Mental health affects well-being and physical health. Among adults with chronic kidney disease (CKD), mental health (MH) problems are common and can induce adverse clinical outcomes. We examined the association between patient-reported MH problems and clinical outcomes in adults with non-dialysis CKD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!